The observation that BMP4 promotes HCV replication suggests a new therapeutic target for treating chronic hepatitis C. Furthermore, reports showing a role for BMP4 in liver development and in the response to injury suggests that targeting this pathway may have profound effects on pathophysiologically relevant processes in liver disease and carcinogenesis. The gene discussed is BMP4; the disease is chronic hepatitis C virus infection.